EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
Monthly Return of Equity Issuer on Movements in Securities
VOLUNTARY ANNOUNCEMENT - THE PROGRESS OF PROPOSED ISSUE OF A SHARES
INSIDE INFORMATION HEALTH CANADA ACCEPTED PRE-CTA MEETING REQUEST FOR RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR)
Form of Proxy for use at the 2019 Annual General Meeting to be held on Friday, May 15, 2020
INSIDE INFORMATION PHASE II CLINICAL TRIAL PLAN FOR RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR)
VOLUNTARY ANNOUNCEMENT - THE PROGRESS OF PROPOSED ISSUE OF A SHARES
INSIDE INFORMATION THE PROGRESS OF PROPOSED ISSUE OF A SHARES FINANCIAL INFORMATION IN RELATION TO A SHARE PROSPECTUS
2019 AGM CIRCULAR
NOTICE OF 2019 ANNUAL GENERAL MEETING
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2019
1
42
43
44
45
46
52
津公网安备12011602300399
